Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Conditional Genetic Ablation Mouse Models as a Tool to Study Cancer Immunosurveillance In Vivo.

Dupont M, Vosshenrich CAJ.

Methods Mol Biol. 2019;1884:161-176. doi: 10.1007/978-1-4939-8885-3_11.

2.

Developmental options and functional plasticity of innate lymphoid cells.

Lim AI, Verrier T, Vosshenrich CA, Di Santo JP.

Curr Opin Immunol. 2017 Feb;44:61-68. doi: 10.1016/j.coi.2017.03.010. Epub 2017 Mar 28. Review.

PMID:
28359987
3.

Phenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells.

Verrier T, Satoh-Takayama N, Serafini N, Marie S, Di Santo JP, Vosshenrich CA.

J Immunol. 2016 Jun 1;196(11):4731-8. doi: 10.4049/jimmunol.1502673. Epub 2016 Apr 22.

4.

Notch signaling in group 3 innate lymphoid cells modulates their plasticity.

Chea S, Perchet T, Petit M, Verrier T, Guy-Grand D, Banchi EG, Vosshenrich CA, Di Santo JP, Cumano A, Golub R.

Sci Signal. 2016 May 3;9(426):ra45. doi: 10.1126/scisignal.aaf2223.

5.

Transcriptional regulation of innate lymphoid cell fate.

Serafini N, Vosshenrich CA, Di Santo JP.

Nat Rev Immunol. 2015 Jul;15(7):415-28. doi: 10.1038/nri3855. Epub 2015 Jun 12. Review.

6.

A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice.

Sepulveda FE, Maschalidi S, Vosshenrich CA, Garrigue A, Kurowska M, Ménasche G, Fischer A, Di Santo JP, de Saint Basile G.

Blood. 2015 Feb 26;125(9):1427-34. doi: 10.1182/blood-2014-09-602946. Epub 2014 Dec 18.

7.

Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases.

Merzoug LB, Marie S, Satoh-Takayama N, Lesjean S, Albanesi M, Luche H, Fehling HJ, Di Santo JP, Vosshenrich CA.

Eur J Immunol. 2014 Nov;44(11):3380-91. doi: 10.1002/eji.201444643. Epub 2014 Sep 19.

8.

Gata3 drives development of RORγt+ group 3 innate lymphoid cells.

Serafini N, Klein Wolterink RG, Satoh-Takayama N, Xu W, Vosshenrich CA, Hendriks RW, Di Santo JP.

J Exp Med. 2014 Feb 10;211(2):199-208. doi: 10.1084/jem.20131038. Epub 2014 Jan 13.

9.

The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies.

Vallese D, Negroni E, Duguez S, Ferry A, Trollet C, Aamiri A, Vosshenrich CA, Füchtbauer EM, Di Santo JP, Vitiello L, Butler-Browne G, Mouly V.

Mol Ther. 2013 Oct;21(10):1950-7. doi: 10.1038/mt.2013.186. Epub 2013 Aug 23.

10.

Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.

Klein Wolterink RG, Serafini N, van Nimwegen M, Vosshenrich CA, de Bruijn MJ, Fonseca Pereira D, Veiga Fernandes H, Hendriks RW, Di Santo JP.

Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10240-5. doi: 10.1073/pnas.1217158110. Epub 2013 Jun 3.

11.

Developmental programming of natural killer and innate lymphoid cells.

Vosshenrich CA, Di Santo JP.

Curr Opin Immunol. 2013 Apr;25(2):130-8. doi: 10.1016/j.coi.2013.02.002. Epub 2013 Mar 13. Review.

12.

Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.

Satoh-Takayama N, Lesjean-Pottier S, Sawa S, Vosshenrich CA, Eberl G, Di Santo JP.

Eur J Immunol. 2011 Mar;41(3):780-6. doi: 10.1002/eji.201040851. Epub 2011 Feb 1.

13.

IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

Elkabets M, Ribeiro VS, Dinarello CA, Ostrand-Rosenberg S, Di Santo JP, Apte RN, Vosshenrich CA.

Eur J Immunol. 2010 Dec;40(12):3347-57. doi: 10.1002/eji.201041037.

14.

The intrathymic crossroads of T and NK cell differentiation.

Klein Wolterink RG, García-Ojeda ME, Vosshenrich CA, Hendriks RW, Di Santo JP.

Immunol Rev. 2010 Nov;238(1):126-37. doi: 10.1111/j.1600-065X.2010.00960.x. Review.

15.

Cutting edge: Thymic NK cells develop independently from T cell precursors.

Ribeiro VS, Hasan M, Wilson A, Boucontet L, Pereira P, Lesjean-Pottier S, Satoh-Takayama N, Di Santo JP, Vosshenrich CA.

J Immunol. 2010 Nov 1;185(9):4993-7. doi: 10.4049/jimmunol.1002273. Epub 2010 Oct 1.

16.

A 'natural' way to provide innate mucosal immunity.

Di Santo JP, Vosshenrich CA, Satoh-Takayama N.

Curr Opin Immunol. 2010 Aug;22(4):435-41. doi: 10.1016/j.coi.2010.05.004. Epub 2010 Jun 21. Review.

17.

IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.

Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP.

J Exp Med. 2010 Feb 15;207(2):273-80. doi: 10.1084/jem.20092029. Epub 2010 Feb 8.

18.

The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.

Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP.

J Immunol. 2009 Nov 15;183(10):6579-87. doi: 10.4049/jimmunol.0901935. Epub 2009 Oct 21.

19.

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP.

Immunity. 2008 Dec 19;29(6):958-70. doi: 10.1016/j.immuni.2008.11.001. Epub 2008 Dec 11.

20.

CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells.

Vosshenrich CA, Lesjean-Pottier S, Hasan M, Richard-Le Goff O, Corcuff E, Mandelboim O, Di Santo JP.

J Exp Med. 2007 Oct 29;204(11):2569-78. Epub 2007 Oct 8.

21.

Developmental pathways that generate natural-killer-cell diversity in mice and humans.

Huntington ND, Vosshenrich CA, Di Santo JP.

Nat Rev Immunol. 2007 Sep;7(9):703-14. Review.

PMID:
17717540
22.

Bone marrow versus thymic pathways of natural killer cell development.

Di Santo JP, Vosshenrich CA.

Immunol Rev. 2006 Dec;214:35-46. Review.

PMID:
17100874
23.

A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127.

Vosshenrich CA, García-Ojeda ME, Samson-Villéger SI, Pasqualetto V, Enault L, Richard-Le Goff O, Corcuff E, Guy-Grand D, Rocha B, Cumano A, Rogge L, Ezine S, Di Santo JP.

Nat Immunol. 2006 Nov;7(11):1217-24. Epub 2006 Oct 1. Erratum in: Nat Immunol. 2006 Dec;7(12):1343.

PMID:
17013389
24.

Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients.

Liu A, Vosshenrich CA, Lagresle-Peyrou C, Malassis-Seris M, Hue C, Fischer A, Di Santo JP, Cavazzana-Calvo M.

Blood. 2006 Aug 15;108(4):1123-8. Epub 2006 Apr 13.

PMID:
16614244
25.

Distinguishing features of developing natural killer cells.

Vosshenrich CA, Samson-Villéger SI, Di Santo JP.

Curr Opin Immunol. 2005 Apr;17(2):151-8. Review.

PMID:
15766674
26.

Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.

Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP.

J Immunol. 2005 Feb 1;174(3):1213-21.

27.

Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment.

Vosshenrich CA, Cumano A, Müller W, Di Santo JP, Vieira P.

Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11070-5. Epub 2004 Jul 19.

28.

Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation.

Samson SI, Mémet S, Vosshenrich CA, Colucci F, Richard O, Ndiaye D, Israël A, Di Santo JP.

Blood. 2004 Jun 15;103(12):4573-80. Epub 2004 Feb 5.

PMID:
14764534
29.

GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells.

Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CA, Colucci F, Buer J, Grosveld F, Godin I, Di Santo JP.

Immunity. 2003 Nov;19(5):701-11.

30.

Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development.

Vosshenrich CA, Cumano A, Müller W, Di Santo JP, Vieira P.

Nat Immunol. 2003 Aug;4(8):773-9. Epub 2003 Jul 20.

PMID:
12872121
31.

IL-15 availability conditions homeostasis of peripheral natural killer T cells.

Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, Lehuen A, Di Santo JP.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2663-8. Epub 2003 Feb 21.

32.

IL-15 is an essential mediator of peripheral NK-cell homeostasis.

Ranson T, Vosshenrich CA, Corcuff E, Richard O, Müller W, Di Santo JP.

Blood. 2003 Jun 15;101(12):4887-93. Epub 2003 Feb 13.

PMID:
12586624
33.

Interleukin signaling.

Vosshenrich CA, Di Santo JP.

Curr Biol. 2002 Nov 19;12(22):R760-3. No abstract available.

34.

B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice.

Montrasio F, Cozzio A, Flechsig E, Rossi D, Klein MA, Rülicke T, Raeber AJ, Vosshenrich CA, Proft J, Aguzzi A, Weissmann C.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4034-7. Epub 2001 Mar 13.

35.

Cytokines: IL-21 joins the gamma(c)-dependent network?

Vosshenrich CA, Di Santo JP.

Curr Biol. 2001 Mar 6;11(5):R175-7.

36.

Common cytokine receptor gamma chain (gammac)-deficient B cells persist in T cell-deficient gammac-mice and respond to a T-independent antigen.

Vosshenrich CA, Sharara LI, Guy-Grand D, Rajewsky K, Müller W, Di Santo JP.

Eur J Immunol. 2000 Jun;30(6):1614-22.

37.

On the role of the common cytokine receptor gamma chain in B-cell vs. T-cell development.

Sharara LI, Vosshenrich CA, Müller W, DiSanto JP.

Res Immunol. 1997 Sep;148(7):449-53. Review. No abstract available.

PMID:
9498003
38.

Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination.

Betz UA, Vosshenrich CA, Rajewsky K, Müller W.

Curr Biol. 1996 Oct 1;6(10):1307-16.

Supplemental Content

Loading ...
Support Center